Prognostic significance of ras/p21 alterations in human ovarian cancer
1997

Prognostic Significance of Ras/p21 Alterations in Ovarian Cancer

Sample size: 109 publication Evidence: moderate

Author Information

Author(s): G Scambia, V Masciullo, P Benedetti Panicil, M Marone, G Ferrandina, N Todaro, A Bellacosa, SK Jain, G Neri, A Piffanelli, S Mancuso

Primary Institution: Catholic University, Rome, Italy

Hypothesis

Can p21 protein levels and K-ras mutations serve as prognostic factors in ovarian cancer?

Conclusion

Higher levels of p21 protein are associated with shorter overall and progression-free survival in ovarian cancer patients.

Supporting Evidence

  • p21 levels were significantly higher in malignant tumours compared to benign tumours.
  • Patients with p21-positive tumours had a median overall survival of 20 months.
  • p21 positivity was associated with shorter progression-free survival.

Takeaway

This study found that a protein called p21 can help doctors predict how well patients with ovarian cancer will do, with higher levels meaning a worse outlook.

Methodology

The study analyzed p21 expression and K-ras mutations in various ovarian cancer samples using Western blot and PCR techniques.

Limitations

The study was conducted at a single institution and may not be generalizable to all populations.

Participant Demographics

Patients undergoing surgery for ovarian cancer between 1988 and 1991.

Statistical Information

P-Value

P < 0.03

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication